Confidence Gap in Europe—against Masks and Vaccinations

Confidence Gap in Europe—against Masks and Vaccinations


Recently, several consecutive anti-vaccine parades have plunged Europe into fear of the second epidemic.

Anti-vaccine Parades 
On the last weekend of August, in order to protest against vaccines, more than 10,000 British people rushed to London from all over the country to gather and March, without social distance and masks. The British police can only send out an open letter, telling people that anyone who attends an assembly of more than 30 people is at risk of being recognized as a criminal offence. As a result, one of the speakers, Piers Corbyn, was taken away by the police wearing a mask, which was the third time he was arrested in the past three months.

China is mostly interested in vaccinating COVID-19 in the world, with 97% of responders willing to vaccinate, followed by Brazil and Australia with 88% willing to vaccinate, followed by India with 87%. In comparison, only 54% of Russian respondents, 56% of Polish and Hungarian respondents, and 59% of French respondents are willing to be vaccinated. The proportion of the United States willing to vaccinate is 67%, which is equal to Italy and Germany.

This is an online questionnaire made by Ipsos, a marketing company, from July 24th to August 7th. For those who are unwilling to be vaccinated, most of the reasons are that they are worried about side effects and have some doubts about the effectiveness of the actual vaccine. There are still a few countries that didn't feel that they were too threatened by vaccines, or have historically opposed all vaccines.

Arnaud Bernaert, head of the Future Health and Medical Platform of the World Economic Forum, said: "The 26% confidence gap in vaccines is important enough to affect the effectiveness of COVID-19 vaccines. Therefore, the government and the private sector need to work together to build confidence and ensure that the production capacity can meet the global vaccine supply. This requires cooperation between researchers and manufacturers, as well as public funds, to ensure that the access channel of vaccines is unobstructed. "